Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial

Arie Pieter Kappetein1*, MD, PhD; Patrick W. Serruys2, MD, PhD; Joseph F. Sabik3, MD; Martin B. Leon4, MD; David P. Taggart5, MD, PhD; Marie-Claude Morice6, MD; Bernard J. Gersh7, MD; Stuart J. Pocock8, PhD; David J. Cohen9, MD; Lars Wallentin10, MD, PhD; Ori Ben-Yehuda4, MD; Gerrit-Anne van Es11, PhD; Charles A. Simonton12, MD; Gregg W. Stone4, PhD

1. Department of Cardiothoracic Surgery, Erasmus Medical Center, Rotterdam, The Netherlands; 2. International Centre for Circulatory Health, NHLI, Imperial College London, London, United Kingdom; 3. Department of Thoracic and Cardiovascular Surgery, The C

Aims: Coronary artery bypass graft (CABG) surgery is the standard of care for revascularisation of patients with left main coronary artery disease (LMCAD). Recent studies have suggested t

Sign in to read and download the full article

Login Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

coronary bypass surgerydrug-eluting stentsleft main diseaserandomised trial

Coronary interventionsStents and scaffoldsLeft main and multivessel diseaseTools, devices and techniquesTools, devices and techniques

Share on Facebook Share on Twitter Share on Linkedin

Read next article

Plaque protrusion compromising bioresorbable coronary scaffold patency